{ "market" : {"NAME" : "U.S.", "ID" : "us_market", "TZ" : "ET", "TZOFFSET" : "-18000", "open" : "1259159416", "close" : "1259182816", "flags" : {}} , "STREAMER_SERVER" : "http://streamerapi.finance.yahoo.com","arrowAsChangeSign" : false,"throttleInterval": "1000"}
prnewswire

Warner Chilcott Announces Earnings Release Date and Conference Call for Third Quarter 2009 Financial Results

  • Press Release
  • Source: Warner Chilcott plc
  • On 4:15 pm EST, Monday November 2, 2009

ARDEE, Ireland, Nov. 2 /PRNewswire-FirstCall/ -- Warner Chilcott plc (Nasdaq: WCRX - News) announced today that it will issue its third quarter 2009 financial results prior to the market opening on Monday, November 9, 2009.

Related Quotes

SymbolPriceChange
WCRX24.22+0.42
Chart for Warner Chilcott plc
{"s" : "wcrx","k" : "c10,l10,p20,t10","o" : "","j" : ""}

In addition to issuing a press release, the Company will host a conference call for all interested parties on Monday, November 9, 2009 at 8:00 AM (Eastern Time) to review the results. To participate in the call, please dial (888) 812-8595 in the United States and Canada or (913) 312-0645 internationally.

Investors and other interested parties may also access the conference call via a simultaneous audio webcast by visiting http://ir.wcrx.com and clicking on Events & Presentations.

A replay of the conference call will be available for two weeks following the call and can be accessed by dialing (888) 203-1112 within the United States and Canada or (719) 457-0820 internationally. The passcode for the replay is 8954946.

The Company

Warner Chilcott is a leading specialty pharmaceutical company currently focused on the women's healthcare, gastroenterology, dermatology and urology segments of the U.S. and Western European pharmaceuticals market. It is a fully integrated company with internal resources dedicated to the development, manufacturing and promotion of its products. WCRX-F

Sponsored Links

Copyright © 2009 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.